COX-2 Gene Promoter Polymorphism and Coronary Artery Disease in Middle-Aged Men: The Helsinki Sudden Death Study

Department of Medical Biochemistry, Medical School, University of Tampere, 33104 Tampere, Finland.
Mediators of Inflammation (Impact Factor: 3.24). 02/2008; 2008(1):289453. DOI: 10.1155/2008/289453
Source: PubMed


Cyclooxygenase (COX) catalyzes formation of prostaglandins that contribute to the inflammation in atherosclerosis. Our objective was to study whether the functional C variant of the polymorphism in the human COX-2 gene associates with the severity of coronary atherosclerosis measured at the coronary artery level. The Helsinki sudden death study autopsy material (n = 300) comprised of Finnish men who died suddenly. The area of atherosclerotic lesions in the coronary arteries was quantitated, and coronary narrowing was measured. The occurrence of myocardial infarction (MI) was assessed. Genotyping was by restriction endonuclease analysis. Men carrying the minor C allele had larger areas of complicated lesions (P = .024) and a higher number of coronary arteries that had over 50%
stenosis (P = .036) compared to men representing the
common GG genotype. The COX-2 polymorphism was not associated with
MI. Our data suggest that COX-2 may be involved in plaque

Download full-text


Available from: Pekka Karhunen, Oct 03, 2015
54 Reads
  • Source
    • "The role of COX-2 has previously been studied in relation to advanced atherosclerosis with clinical complications, such as coronary artery disease [7,8] myocardial infarction and ischemic stroke [9]. However, atherosclerosis begins in childhood and progresses for decades until clinical complications such as myocardial infarction appear [10]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUD: The role of cyclooxygenase-2 (COX-2) single nucleotide polymorphisms has mostly been studied in relation to advanced atherosclerosis, but little is known how they contribute to preclinical disease. In the present study we analyzed whether COX-2 gene variants associate independently with the early subclinical markers of atherosclerosis, carotid intima-media thickness and carotid artery distensibility in a population of young healthy Caucasian adults. SNPs for association analysis were collected from the COX-2 gene and 5 kb up- and downstream of it. There were 19 SNPs available for analysis, four genotyped and fifteen imputed. Genotype data was available for 2442 individuals participating in the Cardiovascular Risk in Young Finns Study. Genotype imputation was performed using MACH 1.0 and HapMap II CEU (release 22) samples as reference. Association analysis was performed using linear regression with an additive model. PLINK was used for true genotyped SNPs and ProbABEL for imputed genotype dosages. False discovery rate was used to take into account multiple testing bias. Two of the COX-2 variants (rs689470, rs689462) associated with distensibility (p = 0.005) under the linear regression additive model. After adjustment with gender, age, body mass index and smoking status, association between these SNPs and distensibility remained significant (p = 0.031). Subjects carrying the minor alleles had higher value of carotid artery distensibility compared to the major allele homozygotes. However, after correcting p-values for multiple testing bias using false discovery rate, association was lost. Another COX-2 variant rs4648261 associated with mean carotid intima-media thickness (p = 0.046) and maximal carotid intima-media thickness (p = 0.048) in the linear regression model. Subjects carrying the minor allele of rs4648261 had lower values of mean and maximal carotid intima-media thickness compared to subjects homozygote for major allele. After adjustments the associations were lost with both mean and maximal carotid intima-media thickness. Thus, no statistically significant associations of the studied COX-2 variants with carotid artery distensibility or carotid intima-media thickness were found. Our results suggest that in a Finnish population, there are no significant associations between COX-2 variants and early atherosclerotic changes in young adulthood.
    BMC Medical Genetics 05/2012; 13(1):32. DOI:10.1186/1471-2350-13-32 · 2.08 Impact Factor
  • Source
    • "Cox-2 expression has been detected in endothelial cells, smooth muscle cells, monocytes, and macrophages within human atherosclerotic lesions. Many PGs produced by the Cox-2 enzyme, including thromboxane, stimulate vasoconstriction, platelet aggregation, and leukocyte-endothelial cell adhesion and so contribute to the formation of thrombosis and atherosclerosis (Huuskonen et al., 2008). Cox-2, which is normally undetectable in most tissues, can be upregulated by bacterial lipopolysaccharides, cytokines, growth factors, and tumor promoters, suggesting its relevance to inflammation (Prescott and Fitzpatrick, 2000; Pisetsky and St. Clair, 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Coronary artery disease is one of the leading causes of mortality and diabetes mellitus is one of its main risk factors due to microvascular and macrovascular complications, such as atherosclerosis. Atherosclerosis is now known to be an inflammatory process mediated by prostaglandins and several interleukins. As both are important in inflammatory processes, we examined Cox-2 (-765G > C) polymorphism and interleukin-6 levels in coronary artery disease patients compared to healthy controls. We also divided the patients into diabetic and non-diabetic groups to check the effects of diabetes mellitus separately. We found that the GG allele frequency was significantly higher in the patient group. Patients with the GG genotype had an approximately 2.78-fold higher risk of coronary artery disease. We also found that the Cox-2 (-765G > C) polymorphism is associated with lower interleukin-6 levels, which decreased in the order: GG > GC > CC.
    Genetics and molecular research: GMR 01/2011; 10(2):810-6. DOI:10.4238/vol10-2gmr967 · 0.78 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Atherosclerosis is a complex multifocal arterial disease involving interactions of multiple genetic and environmental factors. Advances in techniques of molecular genetics have revealed that genetic polymorphisms significantly influence susceptibility to atherosclerotic vascular diseases. A large number of candidate genes, genetic polymorphisms and susceptibility loci associated with atherosclerotic diseases have been identified in recent years and their number is rapidly increasing. In this review we focus on some of the major candidate genes and genetic polymorphisms associated with human atherosclerotic vascular diseases.
    Human Genetics 04/2009; 125(5-6):467-91. DOI:10.1007/s00439-009-0654-5 · 4.82 Impact Factor
Show more